The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...

A COVID-19 study in Britain looked at the medical records of 1.7 million children but did not conclude the same number of ...

Uptake of continuous glucose monitoring (CGM) was relatively low among vulnerable diabetes patients in the largest national ...

BridgeBio Pharma (BBIO) wins FDA nod Attruby for rare heart disorder, ATTR-CM challenging Pfizer's (PFE) Vyndaqel. Read more ...

A young man who allegedly died a “horrific” death after consuming allegedly contaminated antibiotics he bought at a ...

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...

BridgeBio Pharma Inc. gained US approval for a drug to treat a progressive and deadly form of heart disease, paving the way ...

U.S. Sen. Ron Johnson has threatened to issue a subpoena when he becomes chairman of the Permanent Subcommittee on ...

Anthropic announced it received an additional $4 billion investment from Amazon as they deepened their partnership with AWS ...

In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...

President-elect Donald Trump has selected Marty Makary, a Johns Hopkins surgeon who criticized the Biden administration’s ...